New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles

International Journal of Nanomedicine

Volumn 3, Issue 4, 2008, Pages 451-460

  Centelles, Miguel N ^a   Qian, Cheng ^b   Campanero, Miguel A ^a   Irache, Juan M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Bioluminescence; Chitosan; Gene delivery; Hydrodynamics based procedure; Intestine; Nanoparticles

Indexed keywords

BETA GALACTOSIDASE; DNA; GREEN FLUORESCENT PROTEIN; LUCIFERASE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE LOCATION; GENE TRANSFER; HYDRODYNAMICS BASED TRANSFECTION; INTESTINE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; REPRODUCIBILITY; SURFACE PROPERTY; SUSTAINED RELEASE FORMULATION; TRANSGENE;

ANIMALS; CHITOSAN; COMPUTER SIMULATION; DNA; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NANOPARTICLES; ORGAN SPECIFICITY; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 69749104994     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alino SF, Crespo A, Dasi F. 2003. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA. Gene Ther, 10:1672-9.
2. Bloquel C, Trollet C, Pradines E, et al. 2006. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol, 8:6-16.
3. Chen J, Yang WL, Li G, et al. 2004. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol, 10:112-16.
4. Chew JL, Wolfowicz CB, Mao HQ, et al. 2003. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine, 21:2720-9.
5. Chu Q, Joseph M, Przybylska M, et al. 2005. Transient siRNA-mediated attenuation of liver expression from an alpha-galactosidase A plasmid reduces subsequent humoral immune responses to the transgene product in mice. Mol Ther, 12:264-73.
6. Cui Z, Mumper RJ. 2001. Chitosan-based nanoparticles for topical genetic immunization. J Control Release, 75:409-19.
7. Dhawan S, Singla AK, Sinha VR. 2004. Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods. AAPS Pharm Sci Tech, 5(4):e67.
8. Dunlap DD, Maggi A, Soria MR, et al. 1997. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res, 25:3095-101.
9. Ferraris RP, Villenas SA, Diamond J. 1992. Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am J Physiol, 262:1047-59.
10. Gerolami R, Uch R, Jordier F, et al. 2000. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors. Cancer Gene Ther, 7:1286-92.
11. Guliyeva U, Oner F, Ozsoy S, et al. 2006. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm, 62:17-25.
12. Hodges BL, Taylor KM, Joseph MF, et al. 2004. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol Ther, 10:69-78.
13. Illum L, Farraj NF, Davis SS. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res, 11:1186-9.
14. Janes KA, Calvo P, Alonso MJ. 2001. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev, 47:83-97.
15. Kato Y, Onishi H, Machida Y. 2003, Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol, 4:303-9.
16. Kobayashi N, Hirata K, Chen S, et al. 2004. Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: implications for particulate gene delivery systems. J Gene Med, 6:455-63.
17. Koping-Hoggard M, Tubulekas I, Guan H, et al. 2001. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther, 8:1108-21.
18. Koping-Hoggard M, Varum KM, Issa M, et al. 2004. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther, 11: 1441-52.
19. Kramer MG, Barajas M, Razquin N, et al. 2003. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol. Ther, 7:375-85.
20. Litzinger DC, Brown JM, Wala I, et al. 1996. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim Biophys Acta, 1281:139-49.
21. Liu D, Knapp JE. 2001. Hydrodynamics-based gene delivery. Curr Opin Mol Ther, 3:192-97.
22. Liu F, Song Y, Liu D. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther, 6:1258-66.
23. Liu W, Sun S, Cao Z, et al. 2005. An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials, 26:2705-11.
24. MacLaughlin FC, Mumper RJ, Wang J, et al. 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release, 56:259-72.
25. Mumper RJ, Wang JJ, Claspell JM, et al. 1995. Novel polymeric condensing carriers for gene delivery. Proc Int Symp Controlled Release Bioact Mater, 22:178-79.
26. Nash KL, Jamil B, Maguire J, et al. 2004. Hepatocyte-specific gene expression from integrated lentiviral vectors. J Gene Med, 6:974-83.
27. Nishikawa M, Takakura Y, Hashida M. 2005. Pharmacokinetics of plasmid DNA-based non-viral gene medicine. Adv Genet, 53:47-68.
28. Rossmanith W, Chabicovsky M, Herkner K, et al. 2002. Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol, 21:847-53.
29. Roy K, Mao HQ, Huang SK, et al. 1999. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med, 5:387-91.
30. Schipper NG, Varum KM, Artursson P. 1996. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res, 13:1686-92.
31. Sebestyen MG, Budker VG, Budker T, et al. 2006. Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules. J Gene Med, 8:852-73.
32. Smith J, Wood E, Dornish M. 2004. Effect of chitosan on epithelial cell tight junctions. Pharm Res, 21:43-9.
33. Song E, Lee SY, Wang J, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 9:347-51.
34. Van Der Lubben IM, Konings FA, Borchard G, et al. 2001. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target, 9:39-47.
35. Yang PL, Althage A, Chung J, et al. 2002. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A, 99:13825-30.
36. Zhang G, Budker V, Wolff JA. 1999. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther, 10:1735-7.
37. Zhang G, Gao X, Song YK, et al. 2004. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther, 11:675-82.